aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Beam Therapeutics is a US-based biotechnology company focused on developing DNA base editing technologies to treat human diseases. Their core mission is to revolutionize genetic medicine by overcoming the limitations of existing approaches. Beam Therapeutics offers precision genetic medicines through a suite of clinically validated delivery technologies, including electroporation, nonviral, and viral delivery modalities. The company primarily serves the healthcare market in Massachusetts.
Beam Therapeutics has made significant strides in the field of genetic medicine, positioning itself as a leader in DNA base editing. Their innovative approach has garnered attention and investment from notable figures in the biotech industry. The company's impact is evident in its commitment to advancing precision medicine and its potential to transform the treatment landscape for various genetic disorders.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Genetic Medicines
Technology
Biotech
Tags
Healthtech
Revenue Type(s)
Transactional
Customer Type(s)
Enterprise
Geographic Exposure
United States
When was Beam Therapeutics founded?
Beam Therapeutics was founded in 2017.
Where is Beam Therapeutics’s headquarters located?
Beam Therapeutics’s headquarters is located in DE, US.
When was Beam Therapeutics’s last funding round?
Beam Therapeutics’s most recent funding round was for $260M (USD) in January 2021.
How many employees does Beam Therapeutics have?
Beam Therapeutics has 507 employees as of Feb 6, 2024.
How much has Beam Therapeutics raised to-date?
As of July 05, 2023, Beam Therapeutics has raised a total of $689M (USD) since Jan 19, 2021.
Add Comparison
Total Raised to Date
$689M
USD
Last Update Jan 19, 2021
Last Deal Details
$260M
USD
Jan 19, 2021
Post Ipo Equity
Total Employees Over Time
507
As of Feb 2024
Beam Therapeutics Address
Delaware
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts